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Regulation and maintenance of the actin cytoskeleton of podocytes 
has emerged as a critical process for preserving glomerular 
permselectivity. Signaling through nephrin, a crucial component of the 
slit diaphragm, can lead to rearrangement of the actin cytoskeleton. 
Zhu et al. identify phosphoinositide 3-kinase-dependent activation 
of Akt and Rac as mediators of nephrin-induced actin reorganization, 
expanding the signaling network linking two of the podocyte’s unique 
structures, its actin cytoskeleton and the slit diaphragm.
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Podocytes, also known as glomerular 
epithelial cells, possess a unique cellular 
architecture, intertwining to cover the 
glomerular capillary loops with countless 
interdigitating foot processes. Alteration 
of this architecture through a simpliﬁca-
tion of the processes, often termed foot 
process effacement or fusion, appears 
to be a common pathologic response in 
proteinuric diseases. There has therefore 
been considerable scientiﬁc interest in 
how podocytes establish and maintain 
foot processes, and what factors could 
lead to their degeneration. The slit dia-
phragm and the podocyte’s actin cytoskel-
eton have emerged as key contributors to 
the podocyte’s function, and both are dis-
rupted during foot process eﬀacement.
The slit diaphragm is a specialized 
cell–cell adhesion structure that connects 
adjacent foot processes and is thought, 
together with the fenestrated endothe-
lium and the capillary basement mem-
brane, to maintain the permselectivity of 
the glomerulus (reviewed by Tryggvason 
et al.1). Nephrin was the ﬁrst protein to be 
identiﬁed as an integral, and necessary, 
member of the slit diaphragm; mutations 
in nephrin are responsible for congeni-
tal nephrotic syndrome of the Finnish 
type.2 Since that seminal discovery, the 
slit diaphragm has become a desirable 
neighborhood, and the list of proteins 
localized to this structure has steadily 
grown.1 In addition to transmembrane 
proteins, multiple intracellular adaptor 
proteins, structural proteins, and sig-
naling molecules have been reported 
to reside on the cytoplasmic face of the 
structure (reviewed by Benzing3 and 
Faul et al.4). This has led to the realiza-
tion that besides representing a special-
ized cell–cell adhesion, the slit diaphragm 
also plays two additional critical roles: as 
a signaling platform, and as an interface 
for the actin cytoskeleton.
Each foot process contains a central 
actin bundle in addition to a cortical 
network of short, branched actin ﬁbers. 
These structures are disrupted during foot 
process eﬀacement. In addition to con-
necting to the basement membrane via 
focal contacts, actin ﬁlaments also appear 
to link to the slit diaphragm through 
multiple adaptor proteins, including α-
actinin, CD2AP, synaptopodin, and ZO-
1 (reviewed by Faul et al.4) (Figure 1a). 
Mutations in several of these adaptors are 
known to lead to podocyte abnormali-
ties and proteinuric kidney disease in 
humans and mice. The demonstration 
that the slit diaphragm protocadherin 
FAT1 binds to Ena/VASP proteins and 
can thereby induce actin polymeriza-
tion5 hinted that the slit diaphragm not 
only bound to the actin cytoskeleton but 
might regulate its assembly.
Evidence that nephrin itself played a 
critical role in regulating actin dynam-
ics was presented in a series of papers.6–8 
These studies demonstrated that clus-
tering of nephrin leads to phosphoryla-
tion of its cytoplasmic domain by the 
Src-family tyrosine kinase Fyn, which 
had been previously described, gener-
ating binding sites for the SH2 domain 
of Nck1 and Nck2. Nck1 and Nck2 are 
both adaptor proteins characterized by 
a single SH2 domain and several SH3 
domains, which are capable of recruiting 
various regulators of the actin cytoskel-
eton, such as N-WASP and Pak (Figure 
1b). The importance of the Nck proteins 
in podocyte function is underscored by 
the phenotype of mice lacking both nck 
genes in podocytes: they fail to develop 
foot processes and suﬀer from proteinu-
ria and glomerulosclerosis.6 Further-
more, clustering of ectopically expressed 
nephrin or nephrin cytoplasmic domain 
leads to Nck recruitment and localized 
actin polymerization6,8 and, in some 
cases, global changes in cell morphology.7 
Using antibodies raised against a speciﬁc 
phosphotyrosine epitope of nephrin, 
Verma et al.8 further demonstrated that 
nephrin is tyrosine-phosphorylated at 
Y1191 during mouse development, and 
again during protamine-induced foot 
process eﬀacement, but not during nor-
mal adult life. This is in contrast to ﬁnd-
ings reported from rat glomeruli, where 
nephrin is constitutively recognized by 
an anti-phosphotyrosine antibody, but 
phosphorylation decreases during puro-
mycin aminonucleoside-induced podo-
cyte injury.7 Whether this discrepancy 
represents a species diﬀerence, a result 
of diﬀerent speciﬁcities of the antibod-
ies, or other technical issues, remains to 
be resolved. In any case, these studies do 
demonstrate a pathway through which 
nephrin could recruit the machinery nec-
essary to initiate actin polymerization.
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Zhu et al.9 (this issue) examine the role 
of phosphoinositide 3-kinase (PI3K) in 
mediating nephrin’s eﬀect on the actin 
cytoskeleton. The 85-kilodalton regu-
latory domain of PI3K has previously 
been shown to bind to both nephrin and 
its binding partner, CD2AP, in a phos-
phorylation-dependent manner.10 Fur-
thermore, overexpression of nephrin in 
murine podocyte cell lines was reported 
to stimulate the PI3K–AKT pathway, 
thereby enhancing AKT-mediated pro-
survival signals. Zhu et al.9 confirm 
the phosphorylation-dependence of 
the nephrin–PI3K interaction, further 
demonstrating that overexpression of 
Fyn is suﬃcient to mediate this inter-
action. By mutation analysis, nephrin 
Y1152 is shown to be necessary for the 
interaction. This is of particular inter-
est, as Y1152 does not represent a Nck 
binding site. The authors then proceed 
to examine the eﬀect of overexpressing 
nephrin and podocin in a rat podocyte 
cell line. They ﬁnd that overexpression of 
these two proteins leads to activation of 
two downstream targets of PI3K, Akt and 
Rac, a small Rho-GTPase (Figure 1b). 
The activation of both of these eﬀectors 
is abolished by a Src-kinase inhibitor, a 
PI3K inhibitor, or the Y1152F mutation 
in nephrin. In addition, nephrin over-
expression leads to decreased RhoA 
activity and decreased coﬁlin phospho-
rylation (and thus presumed increased 
coﬁlin activation).
In light of the known ability of PI3K and 
its eﬀectors to induce actin cytoskeleton 
rearrangement,11 Zhu et al.9 examine 
the eﬀect of overexpressing nephrin and 
podocin on the actin cytoskeleton of 
rat podocytes. Nephrin overexpression 
led to a loss of stress ﬁbers and cortical 
actin, with a concomitant increase in 
lamellipodia formation. Using a series 
of constitutively active and dominant-
negative forms of Rac and Akt, the authors 
demonstrate that Rac is probably at least 
partially responsible for the increase in 
lamellipodia seen upon nephrin expres-
sion, and that Akt1 is able to reduce stress 
ﬁbers in podocytes but is not necessary 
for nephrin-mediated inhibition of stress 
fibers. Interestingly, overexpression of 
Y1152F mutant nephrin decreased lamel-
lipodia formation and increased stress 
ﬁber formation in relation to wild-type 
glomerular epithelial cells, suggesting 
either that this mutant inhibits subtle 
eﬀects mediated by endogenous nephrin, 
or that other pathways antagonistic to 
PI3K eﬀectors (such as those mediated 
by synaptopodin) may also be activated 
by nephrin.
Finally, as would be predicted from 
the reported decrease in nephrin phos-
phorylation in rats treated with PAN to 
induce transient proteinuria,7 Zhu et 
al.9 report a decrease in the nephrin–
PI3K interaction and a decrease in 
Akt phosphorylation in vivo after PAN 
treatment.
Two important caveats must be kept 
in mind in contemplating the results 
presented by Zhu et al.:9 (1) The sig-
naling events and actin rearrange-
ments described all depended on the 
overexpression of nephrin. It remains 
very much a matter of speculation 
what might regulate nephrin phos-
phorylation and PI3K activation at the 
slit diaphragm in vivo. This is of par-
ticular interest given the discrepancy 
in the data described above regarding 
nephrin phosphorylation in vivo. (2) A 
large canyon lies between the cytoskel-
etal arrangement of podocyte cell lines 
and their in vivo counterparts, making 
any conjecture about how loss of stress 
ﬁbers or increased lamellipodia in tis-
sue culture relates to foot process eﬀace-
ment in vivo highly speculative.
In summary, Zhu and colleagues9 
have added substantially to the list of 
proteins through which nephrin appears 
to modulate the podocyte cytoskeleton. 
Figure 1 | The nephrin–actin network. (a) A subset of interactions through which nephrin is proposed to be linked to the actin cytoskeleton. Nephrin 
is shown in the unphosphorylated state. However, the effect of phosphorylation on most of the interactions depicted here has not been reported.  
(b) Nephrin interactions in response to tyrosine phosphorylation, such as can be mediated by Fyn. The in vivo signals regulating nephrin 
phosphorylation remain obscure. Phosphoinositide 3-kinase (PI3K) binding depends on Y1152 of rat nephrin, whereas Y1204 and Y1228 (and Y1191 
in mice) lie within Nck SH2 binding consensus sequences. PI3K activation leads to an increase in PIP3 at the inner leaflet, recruiting various PH domain-
containing proteins, including Akt and Rac guanine-nucleotide exchange factors. In the case of downstream effects of Akt and Rac activation, arrows 
are not meant to imply a direct effect. Please see Faul et al.4 for additional network connections between the actin cytoskeleton and slit diaphragm 
proteins other than nephrin. Synpo, synaptopodin.
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Two points stand out as being of par-
ticular interest: (1) Nck binding and 
PI3K binding appear to depend on dis-
tinct tyrosine motifs, though binding of 
both appears to be dependent on Fyn. 
(2) Nephrin-mediated PI3K activation 
leads to a loss of stress ﬁbers, whereas 
another slit diaphragm-associated pro-
tein, synaptopodin, has been reported 
to enhance stress ﬁber formation.12
Several interesting questions will 
now need to be addressed: What are 
the in vivo stimuli that lead to nephrin 
phosphorylation? Are Nck and PI3K 
recruited to and activated by nephrin 
independently, simultaneously? Once 
activated, are the signaling pathways 
they activate complementary, synergis-
tic, or antagonistic? Do synaptopodin 
and PI3K play antagonistic roles at the 
slit diaphragm? Perhaps most impor-
tantly, what role do these diﬀerent path-
ways play in vivo in the creation of foot 
processes during development and dur-
ing foot process eﬀacement and recovery 
in adult life? Although much remains to 
be discovered, it appears clear that the 
web connecting the slit diaphragm and 
the actin cytoskeleton will continue to 
grow in complexity and in importance 
for proteinuric kidney disease.
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Animal models of renal disease
K Susztak1, M Bitzer1, TW Meyer2 and TH Hostetter1
Mice have become a favored species to model disease. Many mouse 
strains have proven relatively resistant to some manipulations that 
have generated renal disease in other species. Kirchhoff et al. describe 
a means of producing hypertension, proteinuria, and glomerular 
sclerosis in a mouse strain.
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Clinical work is not enough. The all-important 
thing is to start the derivation of first approxi-
mation answers to clinical questions through 
experimental work on animals.
 -Thomas Addis1
Animal models have been an essential 
component of medical research for cen-
turies. Fulfilling Koch’s postulates usu-
ally requires an animal model as one 
step. Many mechanistic questions can be 
answered only through invasive proce-
dures or extreme exposures possible only 
in animals. Development of therapies 
and detection of toxicities almost always 
involve animal testing. To be sure, models 
can sometimes be uninformative or even 
misleading. Rats resist diphtheria toxin, 
but guinea pigs (and humans) succumb 
to it. Attempts to induce lung cancer with 
cigarette smoke in animals failed. Fleming’s 
initial studies of penicillin in rabbits may 
have retarded its trial in humans, as it was 
rapidly cleared in the animal.
Mice have become a favored species for 
study because their gene expression can 
be altered with relative ease. Indeed, this 
year’s Nobel Prize in Physiology or Medi-
cine went to three scientists instrumental 
in making gene targeting possible. Models 
that test the alteration of a gene suspected 
of having a key role have in some cases sup-
ported that suspicion.2 In other cases, the 
lack of phenotype in a knockout mouse 
may be perplexing.3 Overexpression has 
also been useful in testing a pathway of 
injury, for example, transforming growth 
factor-β.4 For medical researchers, the 
weights of both the positive and the nega-
tive results depend, of course, on whether 
the gene of interest functions and is regu-
lated similarly in mice and humans. This 
may not always be the case.5
Mouse models using single gene knock-
out or overexpression have in many cases 
produced palpable renal disease and 
have in some cases produced diseases 
very faithful to the human condition. 
However, mice have generally not been 
tractable for producing more complex 
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